Quanterix is a company dedicated to transforming healthcare through global collaboration and cutting-edge science. It empowers researchers worldwide to advance precision health by providing innovative biomarker and spatial biology solutions.
The company specializes in ultrasensitive biomarker detection technologies, enabling the measurement of biomarkers at lower levels than ever before. This capability supports breakthroughs in research and diagnostics across various therapeutic areas, including neurology, oncology, immunology, cardiology, and infectious disease.
Quanterix offers integrated platforms such as Simoa® and Spatial Biology solutions, which include instruments, assays, reagents, and software for comprehensive data analysis. These technologies are designed to accelerate biomarker discovery and support translational research from blood to tissue continuum.